| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |